Galanin-like Peptide (Human, 1-60)

Documents

Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-Asp-Gly-Lys-Arg-Glu-Thr-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-His-Pro-Pro-Gln-Pro-Ser
: (M.W. 6500.3) C₂₉₂H₄₅₁N₈₃O₈₄S
: Ligand for Galanin Receptor 2/Target Peptide for Feeding Regulation by Leptin

Package	Price(Yen)	Availability
Vial 0.1 mg	29,000	Ships within 1-3 business days
Bulk Request

Solubility: H₂O (50 μM)

T. Ohtaki, S. Kumano, Y. Ishibashi, K. Ogi, H. Matsui, M. Harada, C. Kitada, T. Kurokawa, H. Onda, and M. Fujino, J. Biol. Chem., 274, 37041 (1999). (Original)
Y. Matsumoto, T. Watanabe, Y. Adachi, T. Itoh, T. Ohtaki, H. Onda, T. Kurokawa, O. Nishimura, and M. Fujino, Neurosci. Lett., 322, 67 (2002). (Stimulation of Food Intake)
H.-M. Tan, A.L. Gundlach, and M.J. Morris, Neuropeptides, 39, 333 (2005). (Pharmacol.; Exaggerated Feeding Response)
A. Juréus, M.J. Cunningham, M.E. Mcclain, D.K. Clifton, and R.A. Steiner, Endocrinology, 141, 2703 (2000). (Pharmacol.)
A.J. Kastin, V. Akerstrom, and L. Hackler, Neuroendocrinology, 74, 423 (2001). (Brain Entry)
A.L. Gundlach, Eur. J. Pharmacol., 440, 255 (2002). (Review)
P.S. Man and C.B. Lawrence, Neuropharmacology, 55 (2008). (Review)
C.B. Lawrence, Physiol. Behav., 97, 515 (2009). (Review)
J.N. Crawley, and G.L. Wenk, Trends Neurosci., 12, 278 (1989). (Review)
T. Bartfai, G. Fisone, and Ü Langel, Trends Pharmacol. Sci., 13, 312 (1992). (Review)
R. Lang, A.L. Gundlach, and B. Kofler, Pharmacol. Ther., 115, 177 (2007). (Review)
I. Mechenthaler, Cell. Mol. Life Sci., 65, 1826 (2008). (Review)

Data Sheet